Earnings History Data for Marinus Pharmaceuticals, Inc. (MRNS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It is focused on developing and commercializing therapeutics for the treatment of epilepsy and other targeted neurological, behavioral and psychiatric disorders. The Company offers Ganaxolone which has completed Phase II clinical trial for the treatment of patients with refractory focal onset seizures. Marinus Pharmaceuticals, Inc. is headquartered in New Haven, Connecticut.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
13-08-2024	PM		MRNS	Marinus Pharmaceuticals	69.00	-0.60	-0.59	0.00	Marinus Pharmaceuticals GAAP EPS of -$0.63 misses by $0.04, revenue of $8.06M misses by $1.45M [8/13/2024 7:01 AM]	1.19	-0.04 (-3.25%)	1.23	0.0 (0.00%)	1.10 - 11.26	314,741	470,000	9,266
Marinus Pharmaceuticals Q2 2024 Earnings Preview [8/12/2024 11:42 AM] Marinus Pharmaceuticals GAAP EPS of -$0.63 misses by $0.04, revenue of $8.06M misses by $1.45M [8/13/2024 7:01 AM]
08-05-2024	PM		MRNS	Marinus Pharmaceuticals, Inc.	80.87	-0.68	-0.68	-0.67	Marinus Pharmaceuticals GAAP EPS of -$0.68 misses by $0.02, revenue of $7.68M misses by $1.48M [5/8/2024 7:22 AM]	1.43	-0.14 (-8.92%)	1.43	0.0 (0.00%)	1.11 - 11.26	2,300,554	1,420,000	6,633
Marinus Pharmaceuticals GAAP EPS of -$0.68 misses by $0.02, revenue of $7.68M misses by $1.48M [5/8/2024 7:22 AM] Marinus Pharmaceuticals Q1 2024 Earnings Preview [5/7/2024 2:08 PM]
05-03-2024	AH		MRNS	Marinus Pharmaceuticals	518.00	-0.74	-0.64	0.00	Marinus Pharmaceuticals GAAP EPS of -$0.74 misses by $0.12, revenue of $7.19M misses by $0.95M [3/5/2024 4:05 PM]	9.05	-0.19 (-2.06%)	8.51	-0.73 (-7.90%)	5.57 - 11.26	1,266,590	340,000	1,022
Marinus Pharmaceuticals GAAP EPS of -$0.74 misses by $0.12, revenue of $7.19M misses by $0.95M [3/5/2024 4:05 PM]
07-11-2023	PM		MRNS	Marinus Pharmaceuticals, Inc.	353.26	-0.61	-0.67	-0.35	Marinus Pharmaceuticals GAAP EPS of -$0.61 beats by $0.06, revenue of $7.34M beats by $1.03M [11/7/2023 7:07 AM]	6.50	-0.09 (-1.44%)	6.70	0.10 (1.52%)	3.46 - 11.15	973,439	430,000	110
Marinus Pharmaceuticals Q3 2023 Earnings Preview [11/6/2023 11:30 AM] Marinus Pharmaceuticals GAAP EPS of -$0.61 beats by $0.06, revenue of $7.34M beats by $1.03M [11/7/2023 7:07 AM] Marinus slips despite guidance raise amid delay for key readout [11/7/2023 1:31 PM]
10-08-2023	PM		MRNS	Marinus Pharmaceuticals, Inc.	450.38	-0.61	-0.76	-1.06	Marinus Pharmaceuticals GAAP EPS of -$0.61 beats by $0.10, revenue of $6.08M beats by $0.34M [8/10/2023 7:14 AM]	7.92	-0.76 (-8.81%)	8.70	0.02 (0.23%)	3.46 - 11.15	1,406,147	490,000	16,584
Marinus Pharmaceuticals Q2 2023 Earnings Preview [8/9/2023 12:05 PM] Marinus Pharmaceuticals GAAP EPS of -$0.61 beats by $0.10, revenue of $6.08M beats by $0.34M [8/10/2023 7:14 AM] Marinus down 8% on delay in late-stage data for seizure asset [8/10/2023 12:09 PM]
11-05-2023	PM	Before the open (May 11)	MRNS	Marinus Pharmaceuticals, Inc.	460.89	-0.67	-0.77	-0.52	Marinus Pharmaceuticals GAAP EPS of -$0.67 beats by $0.13, revenue of $10.38M beats by $5.47M [5/11/2023 7:07 AM]	9.27	-0.31 (-3.29%)	9.58	0.0 (0.00%)	3.46 - 9.82	1,242,524	870,000	4,731
Marinus Pharmaceuticals GAAP EPS of -$0.67 beats by $0.13, revenue of $10.38M beats by $5.47M [5/11/2023 7:07 AM]
07-03-2023	AH	4:00 PM ET (Mar 7)	MRNS	Marinus Pharmaceuticals, Inc.	331.94	-0.76	-0.91	-0.77	Marinus Pharmaceuticals GAAP EPS of -$0.76 misses by $0.16, revenue of $7.16M misses by $1.99M [3/7/2023 4:03 PM]	7.39	0.35 (4.97%)	6.85	-0.19 (-2.70%)	3.46 - 12.37	743,508	520,000	3,733
Marinus Pharmaceuticals GAAP EPS of -$0.76 misses by $0.16, revenue of $7.16M misses by $1.99M [3/7/2023 4:03 PM]
11-08-2022	PM	7:15 AM ET (Aug 11)	MRNS	Marinus Pharmaceuticals, Inc.	218.01	-1.06	-0.93	-0.65	Marinus Pharmaceuticals GAAP EPS of -$1.06 misses by $0.37, revenue of $1.8M misses by $0.51M [8/11/2022 7:34 AM]	5.72	-0.21 (-3.54%)	5.90	-0.03 (-0.51%)	3.97 - 13.15	148,030	220,000	5,263
Marinus Pharmaceuticals Q2 2022 Earnings Preview [8/10/2022 1:49 PM] Marinus Pharmaceuticals GAAP EPS of -$1.06 misses by $0.37, revenue of $1.8M misses by $0.51M [8/11/2022 7:34 AM] Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results [Aug-11-22 07:30AM]
12-05-2022	AH	4:00 PM ET (May 12)	MRNS	Marinus Pharmaceuticals, Inc.	189.17	-0.52	-0.87	-0.74	Marinus Pharmaceuticals GAAP EPS of -$0.52 beats by $0.33, revenue of $14.19M beats by $11.91M [5/12/2022 4:18 PM]	5.69	0.83 (17.08%)	4.92	0.06 (1.23%)	4.19 - 19.83	222,307	280,000	225
Marinus Pharmaceuticals GAAP EPS of -$0.52 beats by $0.33, revenue of $14.19M beats by $11.91M [5/12/2022 4:18 PM] Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results [May-12-22 04:04PM] Marinus Pharmaceuticals (MRNS) Reports Q1 Loss, Tops Revenue Estimates [May-12-22 05:35PM]
21-03-2022	PM	7:00 AM ET (Mar 21)	MRNS	Marinus Pharmaceuticals, Inc.	315.82	-0.77	-0.81	-0.55	Marinus Pharmaceuticals GAAP EPS of -$0.77 misses by $0.02, revenue of $1.52M misses by $1.98M [3/21/2022 7:18 AM]	8.71	-1.29 (-12.90%)	9.10	-0.90 (-9.00%)	7.16 - 19.83	1,065,644	310,158	91,605
Marinus Pharmaceuticals GAAP EPS of -$0.77 misses by $0.02, revenue of $1.52M misses by $1.98M [3/21/2022 7:18 AM] Marinus Pharma falls as Q4 earnings miss adds to trial delays [3/21/2022 11:14 AM] UPDATE 2-U.S. FDA approves Marinus Pharma's drug to treat seizures; shares jump [Mar-18-22 02:44PM] Marinus Pharmaceuticals Announces FDA Approval of ZTALMY® (ganaxolone) for CDKL5 Deficiency Disorder [Mar-18-22 02:29PM] Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results [Mar-21-22 07:15AM] Marinus Pharmaceuticals (MRNS) Reports Q4 Loss, Misses Revenue Estimates [Mar-21-22 08:25AM] Marinus (MRNS) Gets FDA Nod for Ztalmy in Rare Genetic Disorder [Mar-21-22 09:52AM]
09-11-2021	PM	7:00 AM ET (Nov 9)	MRNS	Marinus Pharmaceuticals, Inc.	467.23	-0.53	-0.62	-0.51	Marinus Pharmaceuticals EPS beats by $0.12, beats on revenue [11/9/2021 7:09 AM]	12.72	-0.09 (-0.70%)	12.81	0.0 (0.00%)	10.71 - 20.04	119,280	160,000	3,384
Marinus Pharmaceuticals Q3 2021 Earnings Preview [11/8/2021 12:28 PM] Marinus Pharmaceuticals EPS beats by $0.12, beats on revenue [11/9/2021 7:09 AM] Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Nov-08-21 05:00PM] Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2021 Financial Results [Nov-09-21 07:00AM] Marinus Pharmaceuticals (MRNS) Reports Q3 Loss, Tops Revenue Estimates [Nov-09-21 08:15AM]
10-08-2021	PM	7:30 AM ET (Aug 10)	MRNS	Marinus Pharmaceuticals, Inc.	472.63	-0.65	-0.68	-0.64	Marinus Pharmaceuticals EPS beats by $0.04, misses on revenue [8/10/2021 7:08 AM]	13.12	0.32 (2.50%)	13.12	0.0 (0.00%)	6.84 - 20.04	285,600	170,000	191
Marinus Pharmaceuticals EPS beats by $0.04, misses on revenue [8/10/2021 7:08 AM] Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2021 Financial Results [Aug-10-21 07:00AM] Marinus Pharmaceuticals (MRNS) Reports Q2 Loss, Lags Revenue Estimates [Aug-10-21 08:15AM]
17-05-2021	PM	7:00 AM ET (May 17)	MRNS	Marinus Pharmaceuticals, Inc.	516.23	-0.74	-0.46	-1.28	Marinus Pharmaceuticals EPS misses by $0.29, misses on revenue; issues FY 2021 guidance [5/17/2021 7:38 AM]	15.05	-1.13 (-6.98%)	16.18	0.0 (0.00%)	6.04 - 20.04	381,448	200,000	3,417
Marinus Pharmaceuticals EPS misses by $0.29, misses on revenue; issues FY 2021 guidance [5/17/2021 7:38 AM] Marinus Pharmaceuticals, Inc. to Host Earnings Call [May-17-21 06:45AM] Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2021 Financial Results [May-17-21 07:30AM] Marinus Pharmaceuticals (MRNS) Reports Q1 Loss, Misses Revenue Estimates [May-17-21 08:55AM]
09-03-2021	PM	7:30 AM ET (Mar 9)	MRNS	Marinus Pharmaceuticals, Inc.	588.76	-0.55	-0.52	-1.04	Marinus Pharmaceuticals EPS misses by $0.05, beats on revenue [3/9/2021 7:02 AM]	18.60	1.88 (11.27%)	17.00	0.28 (1.67%)	4.16 - 19.12	737,925	353,847	5,923
Marinus Pharmaceuticals EPS misses by $0.05, beats on revenue [3/9/2021 7:02 AM] Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter 2020 Financial Results [Mar-09-21 07:00AM] Marinus Pharmaceuticals, Inc. to Host Earnings Call [Mar-09-21 05:30AM] Marinus Pharmaceuticals (MRNS) Reports Q4 Loss, Lags Revenue Estimates [Mar-09-21 08:55AM]
09-11-2020	AH	4:15 PM ET (Nov 9)	MRNS	Marinus Pharmaceuticals, Inc.	412.73	-0.51	-0.62	-1.04	Marinus Pharmaceuticals EPS beats by $0.09, misses on revenue [11/9/2020 4:33 PM]	13.84	0.13 (0.95%)	14.66	0.95 (6.93%)	4.04 - 16.28	396,838	406,137	5,484